Skip to main content
. 2015 Oct 7;2015(10):CD010081. doi: 10.1002/14651858.CD010081.pub2

EUCTR2007‐000534‐39.

Methods This is a parallel group RCT
Participants The trial included adults aged 18 to 70 with Hurley stage I to II HS
Interventions
  • Intradermal botulinum toxin injection ‐ dose not stated ‐ versus placebo

Outcomes
Notes The trial was registered in 2007; we are uncertain if it has been completed